Literature DB >> 3474930

The interaction of acetaldehyde with tubulin.

D J Tuma, R B Jennett, M F Sorrell.   

Abstract

Acetaldehyde covalently binds to purified tubulin in vitro to form both stable and unstable adducts. The formation of stable adducts can be greatly facilitated by the inclusion of the relatively gentle and Schiff base specific reducing agent, sodium cyanoborohydride. Although the tubulin molecule has multiple lysine resides available to react with acetaldehyde, certain key lysine residues on the alpha-chain appear to be selective targets for adduct formation. The formation of alpha-chain specific stable acetaldehyde-tubulin adducts results in functional impairment of the ability of tubulin to polymerize. Under relatively physiologic conditions where acetaldehyde-to-protein ratios are low, alpha-chain specific binding is prominent. These results, coupled with the studies presented in another report in this volume, raise the possibility that low levels of adduct formation may be detrimental to the structure or function of certain proteins (e.g. tubulin) in the liver. The alteration of this or other biologically important proteins by sustained low levels of adduct formation may contribute to the pathogenesis of alcoholic liver injury.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3474930     DOI: 10.1111/j.1749-6632.1987.tb48681.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

1.  Biological markers for increased risk of alcoholism and for quantitation of alcohol consumption.

Authors:  D W Crabb
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

2.  New Evidence for the Diversity of Mechanisms and Protonated Schiff Bases Formed in the Non-Enzymatic Covalent Protein Modification (NECPM) of HbA by the Hydrate and Aldehydic Forms of Acetaldehyde and Glyceraldehyde.

Authors:  Justin Lewis; Brandy A Smith; Heaton Oakes; R W Holman; Kenneth J Rodnick
Journal:  Cogent Biol       Date:  2019-02-20

Review 3.  Alcohol-induced alterations of the hepatocyte cytoskeleton.

Authors:  Blythe D Shepard; Pamela L Tuma
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

4.  Isolation and characterization of a Chinese hamster ovary cell line deficient in fatty alcohol:NAD+ oxidoreductase activity.

Authors:  P F James; W B Rizzo; J Lee; R A Zoeller
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

5.  Acetaldehyde substoichiometrically inhibits bovine neurotubulin polymerization.

Authors:  S L Smith; R B Jennett; M F Sorrell; D J Tuma
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

6.  Excessive alcohol consumption favours high risk polyp or colorectal cancer occurrence among patients with adenomas: a case control study.

Authors:  M Bardou; S Montembault; V Giraud; A Balian; E Borotto; C Houdayer; F Capron; J-C Chaput; S Naveau
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

7.  Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts.

Authors:  W B Rizzo; D A Craft
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

8.  Alcohol consumption impairs hepatic protein trafficking: mechanisms and consequences.

Authors:  Blythe D Shepard; David J Fernandez; Pamela L Tuma
Journal:  Genes Nutr       Date:  2009-11-05       Impact factor: 5.523

Review 9.  The Altered Hepatic Tubulin Code in Alcoholic Liver Disease.

Authors:  Jennifer L Groebner; Pamela L Tuma
Journal:  Biomolecules       Date:  2015-09-18

10.  Modification of carbonic anhydrase II with acetaldehyde, the first metabolite of ethanol, leads to decreased enzyme activity.

Authors:  Fatemeh Bootorabi; Janne Jänis; Jarkko Valjakka; Sari Isoniemi; Pirjo Vainiotalo; Daniela Vullo; Claudiu T Supuran; Abdul Waheed; William S Sly; Onni Niemelä; Seppo Parkkila
Journal:  BMC Biochem       Date:  2008-11-27       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.